Apoptosis of articular chondrocytes is associated with the pathogenesis of osteoarthritis (OA). Recently, we demonstrated that hypoxia-inducible factor (HIF)-2a, encoded by Epas1, causes OA cartilage destruction by regulating the expression of various matrix-degrading enzymes. Here, we investigated the involvement of HIF-2a in chondrocyte apoptosis and OA cartilage destruction. HIF-2a levels in human and mouse OA chondrocytes were markedly elevated in association with increased apoptosis of articular chondrocytes. Overexpression or knockdown of HIF-2a alone did not cause chondrocyte apoptosis. However, HIF-2a expression markedly increased chondrocyte apoptosis in the presence of an agonistic anti-Fas (CD95) antibody. HIF-2a enhanced Fas expression and potentiated downstream signaling pathways, increasing the activity of initiator and executioner caspases. Overexpression of HIF-2a in mouse cartilage tissue, either by intra-articular injection of Epas1 adenovirus (Ad-Epas1) or in the context of chondrocyte-specific Epas1 transgenic mice, increased chondrocyte apoptosis and cartilage destruction. In contrast, chondrocyte-specific knockout of Epas1 in mice suppressed DMM (destabilization of the medial meniscus)-induced chondrocyte apoptosis and inhibited OA cartilage destruction. Moreover, Fas-deficient mice exhibited diminished chondrocyte apoptosis and OA cartilage destruction in response to Ad-Epas1 injection or DMM surgery. Taken together, our results demonstrate that HIF-2a potentiates Fas-mediated chondrocyte apoptosis, which is associated with OA cartilage destruction. Osteoarthritis (OA) is a degenerative disease characterized by destruction of articular cartilage. The chondrocyte is a unique cell type in articular cartilage that is responsible for cartilage homeostasis and OA pathogenesis. A variety of potential OA-causing mechanisms have been proposed, including those involving biophysical influences and biochemical factors.
Osteoarthritis (OA) is a degenerative disease characterized by destruction of articular cartilage. The chondrocyte is a unique cell type in articular cartilage that is responsible for cartilage homeostasis and OA pathogenesis. A variety of potential OA-causing mechanisms have been proposed, including those involving biophysical influences and biochemical factors.
1,2 OA pathogenesis is associated with inflammatory responses, a reduced ability of chondrocytes to produce extracellular matrix, and degradation of extracellular matrix molecules by catabolic matrix-degrading enzymes. 1, 2 Apoptosis of chondrocytes and the consequent reduction in tissue cellularity are also involved in the pathogenesis of OA. 3, 4 Increased apoptosis of chondrocytes is correlated with the severity of human OA cartilage damage. 5, 6 Apoptotic chondrocytes are found more frequently in cartilage lesions than in non-lesional areas, 7 and cartilage regions containing apoptotic chondrocytes show proteoglycan depletion.
However, the precise functional relationship between OA and chondrocyte apoptosis is not yet clearly understood. Chondrocytes undergo apoptosis in response to a number of stimuli, including serum starvation, Fas ligand (FasL) or anti-Fas antibody, and nitric oxide donors. 3, 4 Fas (CD95), a member of the tumor necrosis factor receptor family, is a death domain-containing receptor that activates apoptosis signaling. Binding of FasL or agonistic anti-Fas antibody to the Fas receptor triggers apoptotic signals. 3, 4 Although the role of Fas in chondrocyte apoptosis is controversial, 9 many lines of evidence support such an association. 3, 4 For instance, Fas expression is elevated in OA cartilage compared with normal cartilage. 10, 11 In human cartilage, Fas expression is higher in close proximity to OA lesions than in regions distal to the lesion. 7 Fas levels are also reported to be higher in aged cartilage, and are correlated with the decreased cellularity in rabbit articular cartilage during aging. 12, 13 Additionally, a significant amount of soluble FasL is found in the synovial fluid of OA patients, 14 although it is the membrane-bound form of Fas that is associated with apoptotic cell death. Collectively, these observations suggest that Fas and its ligand are physiologically involved in chondrocyte apoptosis.
Recently, we demonstrated that the transcription factor hypoxia-inducible factor (HIF)-2a, encoded by Epas1, is a catabolic regulator of cartilage destruction that acts by regulating the expression of various catabolic factors, including matrix-degrading enzymes and inflammation mediators. 15 In these previous studies, we found that HIF-2a expression was upregulated by pro-inflammatory cytokines, such as interleukin-1b (IL1b). Its expression was also markedly increased in human and mouse OA cartilage. Moreover, intra-articular injection of an Epas1-expressing adenovirus (Ad-Epas1) triggered articular cartilage destruction in mice and rabbits. Chondrocyte-specific Epas1 transgenic (TG) mice displayed spontaneous cartilage destruction, whereas Epas1 knockdown in mice (Epas1 þ /-) suppressed cartilage destruction caused by destabilization of the medial meniscus (DMM). 15 Although it is evident that HIF-2a is a catabolic regulator of OA cartilage destruction, it is not known whether HIF-2a regulates chondrocyte apoptosis in OA cartilage. Therefore, we investigated the function of HIF-2a in chondrocyte apoptosis and evaluated its link to cartilage destruction. For this purpose, we first examined the role of HIF-2a in the apoptosis of primary cultured mouse articular chondrocyte caused by anti-Fas antibody, which mimics FasL. As this in vitro system may not represent the in vivo situation, we evaluated HIF-2a function in Fas-induced chondrocyte apoptosis, and its possible link to OA cartilage destruction in vivo using human OA cartilage and various mouse models of OA cartilage, namely STR/ort, DMM surgery, Ad-Epas1 injection, and chondrocyte-specific Epas1 TG mice. We additionally used HIF-2a-and Fas-deficient mouse models. Here we report that HIF-2a potentiates Fas-mediated chondrocyte apoptosis by upregulating Fas expression and amplifying Fas-induced apoptotic signaling in chondrocytes.
Results
Chondrocyte apoptosis in human and mouse OA cartilage. We first examined chondrocyte apoptosis in human OA and experimental mouse OA cartilage to determine the correlation between HIF-2a expression and chondrocyte apoptosis during OA cartilage destruction. Apoptosis was assayed in cartilage tissue sections using TdT-mediated dUTP nick end-labeling (TUNEL) assays. Cartilage destruction was evaluated by alcian blue staining. TUNEL assays revealed a significant increase in the number of apoptotic chondrocytes in association with increased HIF2a expression in OA-affected (damaged) human cartilage compared with normal and undamaged regions of OA cartilage (Figure 1a) . Chondrocyte apoptosis was also examined in STR/ort mice, which are genetically predisposed to develop OA-like lesions in the medial tibial cartilage. 16 STR/ort mice at 28 weeks of age showed increased HIF-2a expression and cartilage destruction compared with CBA control mice. OA cartilage in STR/ort mice also showed a marked increase in the number of TUNEL-positive apoptotic chondrocytes (Figure 1b) . Finally, we induced cartilage destruction in mice using the DMM surgical model. 15, 17 Compared with a sham operation, DMM surgery increased HIF-2a expression and articular cartilage damage in association with an increase in chondrocyte apoptosis ( Figure 1c) . Thus, all examined OA cartilage showed increased HIF-2a expression and chondrocyte apoptosis, suggesting a possible association between HIF-2a expression and chondrocyte apoptosis. 
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Figure 1
Chondrocyte apoptosis in human and mouse OA cartilage. (a) Sulfate proteoglycan and HIF-2a protein were detected by alcian blue and immunohistochemical staining, respectively, in normal cartilage, undamaged regions of OA cartilage, and OA-affected (damaged) human cartilage regions. Apoptotic chondrocytes were identified and quantified by TUNEL staining (n 47). Figure 4) .
Similar to the effects of HIF-2a expression, IL1b treatment enhanced chondrocyte apoptosis in the presence of a low concentration (0.1 mg/ml) of anti-Fas antibody (Figure 3a and Supplementary Figure 5a) . The stimulatory effects of IL1b on chondrocyte apoptosis were statistically significant at concentrations as low as 10 pg/ml, a concentration within the range of that found in the synovial fluid of human OA patients (o20 pg/ml). 18 IL1b additionally enhanced chondrocyte apoptosis at high concentrations of anti-Fas antibody ( Figure 3b) . We have previously shown that IL1b promotes expression of HIF-2a, which, in turn, mediates IL1b-induced expression of catabolic factors in chondrocytes. 15 We therefore examined whether the stimulatory effects of IL1b on chondrocyte apoptosis required HIF-2a expression. siRNAmediated Epas1 knockdown significantly blocked the stimulatory effects of IL1b on chondrocyte apoptosis in the presence of anti-Fas antibody (Figure 3c and Supplementary  Figure 5b) . Therefore, HIF-2a appears to contribute to the induction and enhancement of anti-Fas antibody-dependent chondrocyte apoptosis by IL1b.
HIF-2a regulates chondrocyte apoptosis in OA cartilage. To validate the role of HIF-2a in chondrocyte apoptosis during OA cartilage destruction in vivo, we overexpressed HIF-2a in cartilage tissue by injecting Ad-Epas1 into mouse knee joints. Consistent with our previous results, 15 Ad-Epas1 injection caused HIF-2a overexpression in association with severe cartilage destruction. Under these conditions, chondrocyte apoptosis was significantly increased in OA cartilage (Figure 4a) . Cartilage destruction and a significant increase in chondrocyte apoptosis were also observed in aged (45-week-old) chondrocyte-specific Epas1 TG mice (Figure 4b ), which exhibit spontaneous OA cartilage destruction. 15 The function of HIF-2a in chondrocyte apoptosis in vivo was further characterized using HIF-2a knockout (KO) mice. As homozygous HIF-2a KO mice (Epas1
) die in utero, we used heterozygotes (Epas1 þ /À ) for DMM-induced experimental OA. Consistent with our previous results, 15 DMM caused cartilage destruction in association with an increase in HIF-2a expression in wildtype (WT) mice, whereas both were significantly attenuated in Epas1 þ /À mice ( Figure 4c ). DMM surgery also caused a significant increase in chondrocyte apoptosis in WT mice that paralleled the HIF-2a expression pattern; this too was blocked in Epas1 (Figure 6d ). Finally, we examined Fas expression in chondrocytes of OA cartilage to examine the possible association of Fas upregulation with cartilage destruction. Fas expression was markedly increased in OA cartilage, both in the spontaneous OA cartilage of STR/ort mice and in Ad-Epas1-induced OA cartilage. DMM surgery also increased Fas expression, an effect that was blunted in chondrocyte-specific Epas1 CKO mice (Figure 6e and Supplementary Figures 6b and c) .
As by activating an initiator caspase (e.g. caspase-8), which in turn activates an executioner caspase (e.g. caspase-3), followed by stimulation of a proteolytic cascade. 19 Anti-Fas antibody slightly, but significantly, activated caspase-8 activity, an effect that was dramatically increased by Ad-Epas1 infection or IL1b treatment (Figure 7a ). Anti-Fas antibody more markedly activated caspase-3 than caspase-8. Caspase-3 activity was also markedly increased by Ad-Epas1 infection or IL1b treatment in the presence of anti-Fas antibody (Figure 7b) . Consistent with this, immunofluorescence microscopy (Supplementary Figure 7) and western blot analyses (Figure 7c ) revealed that Ad-Epas1 infection or IL1b treatment increased cleavage of caspase-8, caspase-3, and poly (ADP-ribose) polymerase (PARP). Taken together, our results indicate that HIF-2a stimulates anti-Fas antibodyinduced apoptosis through upregulation of Fas and amplification of downstream signaling.
Fas deficiency in mice inhibits chondrocyte apoptosis and cartilage destruction. Next, we examined the functional relevance of HIF-2a-mediated Fas upregulation in chondrocyte apoptosis and the functional consequence of chondrocyte apoptosis in OA pathogenesis in vivo. To do this, we used the C57BL/6-Lpr/Lpr mouse, which is a Fas-deficient mouse strain. 20 The increase in chondrocyte apoptosis induced by Ad-Epas1 infection in control mice (C57BL/6) was significantly reduced in Fas-deficient C57BL/ 6-Lpr/Lpr mice ( Figure 8a and Supplementary Figure 8 ). Chondrocyte apoptosis caused by DMM surgery was also significantly reduced in Fas-deficient mice (Figure 8b and Supplementary Figure 8) . These results indicate that Fas signaling has an important role in the in vivo chondrocyte apoptosis that takes place during OA cartilage destruction caused by DMM surgery or Ad-Epas1 infection. Finally, the role of Fas in chondrocyte apoptosis was validated using primary cultures of chondrocytes isolated from control and Fas-deficient mice. As expected, anti-Fas antibody-induced chondrocyte apoptosis and the stimulatory effects of AdEpas1 or IL1b were completely abolished in Fas-deficient chondrocytes (Figure 8c ). Furthermore, cartilage destruction induced by Ad-Epas1 infection or DMM surgery was significantly inhibited in C57BL/6-Lpr/Lpr mice, as determined by Makin scores (Figures 8a and b) , supporting a functional link between chondrocyte apoptosis and OA cartilage destruction.
Discussion
Here, we demonstrated that HIF-2a potentiates Fas-mediated chondrocyte apoptosis, which, in turn, is associated with OA cartilage destruction. Although overexpression or knockdown of HIF-2a alone did not modulate chondrocyte apoptosis, HIF-2a markedly potentiated Fas-mediated apoptosis, an action that reflected upregulation of Fas expression and the consequent amplification of apoptotic signaling (see Figure 8d ). We also demonstrated that HIF-2a overexpression in mouse cartilage increased chondrocyte apoptosis and cartilage destruction, whereas Epas1 KO mice showed a reduction in both chondrocyte apoptosis and cartilage destruction. Furthermore, mice lacking the Fas gene exhibited reduced chondrocyte apoptosis and OA cartilage destruction. Therefore, our results provide evidence for a link between chondrocyte apoptosis and cartilage destruction by HIF-2a.
The results of in vitro experiments using articular chondrocytes indicate that HIF-2a causes chondrocyte apoptosis at low concentrations of anti-Fas antibody and markedly enhances apoptosis at high antibody concentrations. The induction and enhancement of chondrocyte apoptosis by HIF-2a appears to be attributable to its capacity to increase Fas expression. Indeed, the Fas gene is a direct target of HIF-2a in mouse articular chondrocytes. The significance of Fas upregulation was directly demonstrated by the observation that knockdown of Fas expression inhibited the potentiation of chondrocyte apoptosis by Ad-Epas1 infection or IL1b treatment. Ligand-stimulated Fas receptors initiate apoptotic signaling by activating an initiator caspase, such as caspase-8, which is activated by self-cleavage. The activated caspase-8, in turn, stimulates an executioner caspase, such as caspase-3, to activate a proteolysis cascade. 19 Consistent with this, HIF-2a potentiated the activation of initiator caspase-8 and effector caspase-3, as well as cleavage of the caspase-3 target protein, PARP. We therefore conclude that HIF-2a potentiates chondrocyte apoptosis through upregulation of Fas and amplification of downstream apoptotic signaling.
We have previously shown that HIF-2a expression is stimulated by IL1b in articular chondrocytes. 15 In the current study, we observed that anti-Fas antibody-induced chondrocyte apoptosis was significantly enhanced by IL1b treatment. The stimulatory effects of IL1b on chondrocyte apoptosis appear to be mediated by HIF-2a expression because knockdown of Epas1 inhibited IL1b-induced enhancement of apoptosis. However, although IL1b-enhanced apoptosis was markedly inhibited in HIF-2a KO chondrocytes, IL1b still enhanced anti-Fas antibody-induced chondrocyte apoptosis. This indicates the existence of HIF-2a-independent apoptosis-inducing mechanisms, although these were not Mouse chondrocytes were treated with IgG (1 mg/ml) or with the indicated amounts (mg/ml) of anti-Fas antibody. Alternatively, the cells were treated with IL1b (ng/ml), empty Ad (Mock; 400 multiplicity of infection (MOI)) or with Ad-Epas1 (at the indicated MOIs) for 24 h, and incubated with 0.1 mg/ml anti-Fas antibody for an additional 6 h. Activities of caspase-8 (a) and caspase-3 (b) were measured using the respective assay kits. Values are presented as means±S.E.Ms. (*Po0.001; n ¼ 6). (c) Mouse articular chondrocytes were untreated or treated with the indicated amounts (ng/ml) of IL1b, or infected with empty Ad (Mock; 400 MOI) or Ad-Epas1 (at the indicated MOIs) for 24 h. The cells were exposed to 0.1 mg/ml of anti-Fas antibody for an additional 6 h. Both pro-forms and cleaved-forms of caspase-3, caspase-8, and PARP on the same blot were detected by western blot analysis using antibodies recognizing both forms explored in this study. The effect of IL1b on chondrocyte apoptosis is a matter of controversy and appears to depend on experimental conditions. Similar to our results, it has been shown that IL1b induces apoptosis of rat 21 and human 22 OA chondrocytes. In contrast, Kü hn et al. 23 have reported that IL1b protects against anti-Fas antibody-induced apoptosis of human chondrocytes. Although additional studies will be required to resolve these discrepancies, they could reflect differences in experimental conditions. We used passage 0 primary cultured mouse articular chondrocytes, whereas Kü hn et al. used second-passage human OA chondrocytes. Serial passage in culture is known to cause a loss of the differentiated chondrocyte phenotype, 24 and such a change in differentiation status could modulate IL1b effects. Another possible explanation for the discrepant findings is a difference in IL1b treatment conditions. Kü hn et al. 23 co-treated chondrocyte with anti-Fas antibody and ILb for 14 h, whereas we pretreated chondrocytes with IL1b or Ad-Epas1 for 24 h before treatment with anti-Fas antibody. Pretreatment with IL1b or HIF-2a overexpression could alter the gene expression profile in chondrocytes, leading to a more apoptosispromoting state. Indeed, we observed that IL1b and HIF-2a enhanced Fas expression in chondrocytes. Nevertheless, our current results clearly indicate that pretreatment with IL1b, and HIF-2a overexpression markedly enhanced chondrocyte apoptosis, suggesting a contribution of HIF-2a to OA cartilage destruction.
The significance of HIF-2a in chondrocyte apoptosis in vivo was suggested by the observations that HIF-2a and Fas levels were markedly increased in human OA cartilage and various mouse models of OA cartilage. Consistent with this, a number of studies have indicated that Fas expression is upregulated in OA chondrocytes. Fas levels are reported to be higher in aged cartilage, and are correlated with the decrease in cellularity in rabbit articular cartilage during aging. 12, 13 Upregulation of Fas is also observed in rabbit chondrocytes after OA induction. 10 In human articular cartilage, expression of Fas is increased in OA chondrocytes, 11 and Fas expression is higher in close proximity to OA lesions than in regions distal to the lesion. 7 In the current study, we found that FasL was expressed in chondrocytes, although the expression levels were low. Other studies have also reported expression of FasL in chondrocytes. For instance, mRNA levels of FasL are higher in aged cartilage, and FasL expression is increased in rabbit OA cartilage. 10, 12 FasL upregulation is also observed in human OA cartilage and chondrocytes. 11 In these previous studies, however, it was not determined whether the increase in FasL mRNA levels resulted in an increase in the expression of membrane-bound FasL, which is linked to the apoptotic pathway. Our current results indicate that HIF-2a upregulates Fas expression without modulating FasL expression in chondrocytes. Therefore, we speculate that increased Fas expression potentiates death signaling in chondrocytes, even in the context of the low FasL levels in chondrocytes. However, this interpretation should be considered with care. Although upregulation of Fas on chondrocytes makes the cells a potential target for Fas/FasL-induced apoptosis, it remains to be clarified whether Fas upregulation is sufficient to cause chondrocyte apoptosis in the presence of low FasL levels. Indeed, aggregation of pre-assembled Fas trimers by FasL trimers or antagonistic Abs has been shown to trigger apoptosis in vivo and in vitro, respectively. 3, 4 Additionally, the dense nature of cartilage matrix and the existence of chondrocyte as single cells in cartilage tissue may hinder the free movement of FasL on the cell membrane, thus interfering with receptor engagement on chondrocytes. However, changes in cartilage stiffness during OA progression, 25 and aggregation of chondrocytes in OA cartilage may make FasL movement and receptor engagement possible.
Consistent with the upregulation of HIF-2a and Fas in OA cartilage, Epas1 þ /À mice and Epas1 CKO mice showed a reduction in both chondrocyte apoptosis and cartilage destruction. The functional relevance of HIF-2a-mediated Fas upregulation in chondrocyte apoptosis and the functional consequence of chondrocyte apoptosis in OA pathogenesis were explored in vivo using C57BL/6-Lpr/Lpr mice, which lack the Fas gene. 20 Mice of the MRL strain with the lymphoproliferation (Lpr) mutation spontaneously develop a complex, rheumatoid arthritis-like immunological disease that is caused by a mutation in the Fas gene. 20 However, other strains of mice with the Lpr mutation, such as C57BL/6, do not develop spontaneous arthritis. 26 Therefore, we used Lpr/Lpr mice inbred on a C57BL/6 background (C57BL/6-Lpr/Lpr) as a Fas-deficient mouse model. Our results indicate that a deficiency of Fas inhibited in vivo chondrocyte apoptosis upon DMM surgery or Ad-Epas1 infection. This supports our hypothesis that induction and enhancement of chondrocyte apoptosis is due to Fas upregulation rather than indirect induction of apoptosis by other deleterious effects of HIF-2a on chondrocytes, such as expression of catabolic factors. Fas-deficient mice also exhibited reduced OA cartilage destruction upon Ad-Epas1 injection or DMM surgery. This supports the functional significance of chondrocyte apoptosis in OA pathogenesis. We have previously shown that HIF-2a regulates the expression of catabolic factors, such as matrix metalloproteinase (MMP) 3 and MMP13, 15 which have crucial roles in OA pathogenesis. 27, 28 Therefore, our current results suggest an essential role for HIF-2a-mediated chondrocyte apoptosis in OA pathogenesis in addition to its role in inducing the expression of catabolic factors, such as matrix-degrading enzymes and inflammation mediators. ; Col2a1-Cre, C57BL/ 6-Lpr/Lpr, STR/ort, and CBA/CaCrl mice were used for experimental OA studies. Chondrocyte-specific Epas1 TG mice were generated using the Col2a1 promoter and enhancer. 20 were purchased from Japan SLC, Inc. (Shizuoka, Japan); C57BL/6 mice were used as a congenic control for Lpr/Lpr mice. Animals were maintained under pathogen-free conditions. All experiments were approved by the Gwangju Institute of Science and Technology Animal Care and Use Committee.
Human OA cartilage and experimental OA in mice. Normal human knee joint cartilage was obtained from patients who experienced meniscus problems during arthroscopic meniscectomy or meniscal repair. Human OA knee joint cartilage was sourced from individuals who had undergone arthroplasty. 15 The Review Board of the Wonkwang University Hospital approved the use of these materials, and all individuals provided informed, written consent before the operative procedure. Spontaneous OA in STR/ort 16 and Epas1 TG mice was examined at 28 and 45 weeks of age, respectively. Experimental OA in mice was induced by DMM surgery; sham-operated mice were used as controls. 15, 17 Experimental OA was also induced by intra-articular injection of Ad-Epas1 (1 Â 10 9 plaque forming units (PFU)) in 10-12-week-old male mice; control mice were injected with empty Ad virus (mock infection). 15 Mice were killed 8 weeks after DMM surgery or 2 weeks after Ad-Epas1 injection for analysis of cartilage tissue.
Histological analysis and apoptosis assay. Normal and OA human cartilage were frozen, sectioned at 6-mm thickness, and fixed in paraformaldehyde. OA cartilage damage was established based on alcian blue staining, and scored according to the International Cartilage Repair Society grading system. 15, 32 HIF-2a protein was detected using standard immunohistochemical staining techniques. 15 Mouse cartilage tissues were fixed in paraformaldehyde, decalcified, embedded in paraffin, and sectioned at 6-mm thickness. Cartilage destruction was evaluated by safranin O staining and was scored according to Mankin's method. 15, 33 For HIF-2a immunohistochemical staining, mouse cartilage tissue was scraped off with a blade and embedded in paraffin after fixation with paraformaldehyde, omitting the decalcification step. HIF-2a was detected in sections (5-mm thick) using standard immunohistochemical staining techniques. 15 Apoptosis of articular chondrocytes in cartilage tissues was determined by TUNEL assay using a kit from Roche Diagnostics (Mannheim, Germany). Specimens were visualized under a fluorescence microscope. The number of apoptotic chondrocytes in relation to the total number of cells was quantified in tissue sections. More than three fields of microscopic view in each section, and multiple sections (more than three) from at least six different experimental animals in each experimental group were used.
Primary culture of articular chondrocytes and apoptosis assay. Mouse articular chondrocytes were obtained from 6-day-old ICR mice, Epas1 fl/fl mice, Epas1 fl/fl ; Col2a1-Cre mice, and C57BL/6-Lpr/Lpr mice. Chondrocytes were isolated from femoral heads, femoral condyles and tibial plateaus of each mouse as described previously, 34 and maintained as a monolayer in Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum. Apoptosis was induced in culture day-3 chondrocytes by treating with anti-mouse Fas antibody. Briefly, chondrocytes were treated for 6 h with the indicated amounts of anti-mouse Fas antibody (BD Biosciences, Franklin Lakes, NJ, USA) in the presence of 0.5 mg/ml of recombinant protein G to enhance receptor cross-linking. Hamster IgG 2 (1 mg/ml) in the presence of protein G was used as a control. The effects of HIF-2a and IL1b were examined by treating chondrocytes with the indicated amount of empty Ad (mock), Ad-Epas1, or IL1b (2 ng/ml) for 24 h. The cells were exposed to anti-Fas antibody and protein G for an additional 6 h. Apoptotic death of chondrocytes was confirmed by TUNEL assay. 35 All experiments with each primary culture were performed in duplicate in Dulbecco's Modified Eagle Medium containing 0.5% fetal bovine serum. n's indicate the number of primary cultures. Chondrocyte apoptosis was also determined by DNA fragmentation assay and flow cytometry based on the number of cells containing fragmented DNA. Apoptotic chondrocytes were quantified by FACS analysis using cells stained with FITC-conjugated annexin V or propidium iodide (BD Biosciences). 35 Assay of Fas expression. mRNA levels of Fas in articular chondrocytes were detected by RT-PCR and quantified by qRT-PCR. PCR primers and experimental conditions are summarized in Supplementary Table 1 . Cell surface
